This federal Project Grant award of $162,000.00 from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a proof-of-concept trial of a technology-delivered mindful walking intervention for Black women with hypertension. The goal is to reduce stress, increase physical activity, and ultimately lower blood pressure in this high-risk population. The 5-year project, with an award start date of August 15, 2024, will be...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $540,798 to The Miriam Hospital to develop an adaptive intervention to help under-resourced cardiac rehabilitation patients maintain improvements in health behaviors after completing Phase II cardiac rehabilitation. The project utilizes a Sequential, Multiple Assignment, Randomized Trial (SMART) design to create a stepped care...
This federal Project Grant award of $722,190 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to optimize an evidence-based physical activity intervention for Latina women by integrating mindfulness-based stress reduction techniques. The primary goal is to improve physical activity adherence and health outcomes in Latina women, who face significant health disparities. The study will first deliver the standard physical activity intervention to...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $1,057,905.00 to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The funding supports a comprehensive, multi-year research program to promote weight-related health and address the full spectrum of weight-related issues among the next generation of adolescents and...
This $347,527.92 Project Grant from the National Heart, Lung and Blood Institute of the Department of Health and Human Services will fund the development of a clinical decision support tool to maximize outcomes for obesity treatment in primary care. The grant recipient, Dr. Hallie Espe-Huynh of The Miriam Hospital, will work with stakeholders to design a machine learning model within a prototype clinical decision support system. The tool aims to predict early risk of nonresponse to online...
This Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to evaluate interventions to reduce food insecurity and improve treatment adherence in patients with hypertension. The key objectives are to determine the most effective initial food insecurity intervention and, for non-responders, evaluate the best subsequent...
This $809,029 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a 3-arm randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing physical activity adherence among patients with heart failure with preserved ejection fraction (HFPEF). The 6-month intervention will examine whether gamification combined with either 'support' or 'competition' can...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to evaluate the impact of recent Medicare policy changes on health outcomes for Medicare beneficiaries with heart failure. The $169,416 award, which begins on July 1, 2024 and runs through June 30, 2029, has three key aims: 1) Determine whether healthcare access, affordability, and clinical outcomes differ between Medicare...
This federal Project Grant award of $120,000 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to establish the feasibility of measuring bereavement-related stress in a naturalistic setting among spousal bereaved individuals. The study will use a novel approach combining ecological momentary assessment with continuous electrocardiography monitoring to generate personalized measures of both affective and autonomic...
This $148,568 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the physiological regulation of energy intake during meals following weight loss. The research will leverage data from two ongoing NIDDK-funded studies - the ARROW study (R01DK114272) and the TIME2EAT study (R01DK132372) - to analyze energy balance, gut hormone...